Information presented on this website is for educational purposes only.
Materials presented have not been evaluated by the U.S. Food & Drug Administration and are not in any way a replacement or substitute for professional medical diagnosis and treatment. 

 
ZHANG CLINIC

20 E. 46th Street
Suite 1402
New York,  NY 10017


Tel:  (212) 573-9584 
Fax: (212) 573-6045 

 

 
Home
Contact Us
Search Site
About Dr. Zhang
Patient Support Forum
username: support
password: support
Dr. Zhang Questions Forum
(Login required. Please email us to receive access)
ZHANG CLINIC Protocol Web
(This is a private sub-web for patients and clinic affiliates only.)
If you need login information, please email us
Complimentary Lyme Disease
Consultation Questionnaire


Information presented on this website is for educational purposes only.
Materials presented have not been evaluated by the U.S. Food & Drug Administration and is not meant to diagnose or treat medical illnesses.
 

 


Philosophical Differences Between Western and Chinese Medicine:

Part 1: Western Medicine
Part 2: Traditional Chinese Medicine
Part 3: Modern Chinese Medicine

 
Liver Disorders
Hepatitis C
Liver Fibrosis
Alcoholic Hepatitis
Non-Alcoholic Steatohepatitis (NASH) or Fatty Liver  
Auto-Immune Hepatitis
Cholestatic Hepatitis
 

Chronic Lyme Disease


IBS/Crohn's Disease


 

Modern Chinese Medicine and Supportive Therapies for Cancer Patients
Artemisinin and its Derivatives
 



 



 

 

 

Overview
Clinical Features of NASH
The severity degrees of NASH
Diagnosis of NASH
MCM Treatments for NASH

Clinical Features of NASH

The enlargement of the liver is one of the major symptoms, which is caused by the reduction of fatty acid oxidation in the liver. This results in the accumulation of fat in the liver. Oftentimes, patients with fatty liver feel severe fatigue and frequent discomfort at the liver area. When the condition become more severe as the accumulation of fat increases, other symptoms such as jaundice, abdominal pain, nausea, vomiting, and tender liver will occur. These symptoms can also be a sign of an underlying liver disease that may be exacerbated by the accumulation of fat in the liver.

Most people become aware of the problem only after a formal examination by their physicians. The results may reveal an enlarged liver along with elevated levels of enzymes such as ALT, AST, GGT, and Alkaline phosphate. Usually ALT is usually more elevated than AST since it is a liver specific enzyme. Aside from blood work, sonograms and CAT scans can also detect fatty liver changes and these methods are usually used for clinical diagnosis.

Histologically, fatty changes in the liver cells are the most obvious characterization. There is also liver cell necrosis, mononuclear and polymorphonuclear inflammatory cells infiltration in the liver lobes.  

The following are the summary of the clinical features of NASH:

  1. The peak age of onset: 47 ~ 55
  2. Gender: Rate in Female > Rate in Male
  3. Obesity: 2/3 patients above the standard body weight
  4. High blood sugar level and abnormal glucose tolerate test (GTT): 50% ~ 90% patients have diabetes or abnormal GTT.
  5. High blood lipids: 30% ~ 90% have high blood lipids  
  6. Concurrent mild ALT and AST elevation.

 

Histology: large fat drops in the liver cells, inflammatory cells infiltration in the portal areas and the lobes, Mallory bodies, and some cases have already progressed to cirrhosis.   

 

 

 

Copyright  2005 Sinomed Research Institute

Medical Information Resources:
http://www.nih.gov/
http://www.nlm.nih.gov/

http://nccam.nih.gov/


Contact the Webmaster

Hit Counter